Elizabeth Nowak

4PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 03, 2026
Systemic pre-conditioning favors effector over exhausted CD8 T-cell subsets following Sup2-IL33 armored CAR T-cell therapy.

|Feb 07, 2025
Targeting cell-surface VISTA expression on allospecific naïve T cells promotes tolerance.

Brent H Koehn, Elizabeth C Nowak, Sladjana Skopelja-Gardner

|Oct 19, 2022
VISTA Targeting of T-cell Quiescence and Myeloid Suppression Overcomes Adaptive Resistance.

Evelien Schaafsma, Walburga Croteau, Mohamed ElTanbouly

|Jan 18, 2020
VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.

Mohamed A ElTanbouly, Yanding Zhao, Elizabeth Nowak

Pageof 1

Frequent Collaborators

2 joint publications

Bruce R Blazar

2 joint publications

Chao Cheng

2 joint publications

Randolph Noelle

2 joint publications

Brent Koehn